Loading…
Evolus, Inc. is projected to rise to $8.73 by 2027, a +32% move from its current price of $6.61. EOLS is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/11/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $6.47 | $6.61 | $6.76 | +0.01% |
| Jul 14 | $6.41 | $6.61 | $6.82 | +0.03% |
| Jul 15 | $6.36 | $6.61 | $6.87 | +0.04% |
| Jul 16 | $6.33 | $6.61 | $6.91 | +0.05% |
| Jul 17 | $6.29 | $6.61 | $6.95 | +0.07% |
| Jul 18 | $6.26 | $6.62 | $6.99 | +0.08% |
| Jul 19 | $6.24 | $6.62 | $7.02 | +0.09% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $6.24 | $6.62 | $7.02 | +0.09% |
| Week 2 | $6.09 | $6.62 | $7.20 | +0.19% |
| Week 3 | $5.99 | $6.63 | $7.34 | +0.28% |
| Week 4 | $5.90 | $6.63 | $7.46 | +0.37% |
| Week 5 | $5.82 | $6.64 | $7.58 | +0.46% |
| Week 6 | $5.75 | $6.65 | $7.68 | +0.56% |
| Week 7 | $5.69 | $6.65 | $7.78 | +0.65% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Evolus, Inc., a performance beauty company, delivers products in the cash-pay aesthetic market in the United States, Canada, Europe, and Australia. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults; and Evolysse, a collection of injectable hyaluronic acid gels, which includes various products, such as mid face, nasolabial folds, lips and eyes. The company was incorporated in 2012 and is headquartered in Newport Beach, California.
Evolus, Inc. (EOLS) is a healthcare stock with a current price of $6.61 and a market cap of $435.3M. It is ranked 3150 by market capitalization.
A major floor 40.4% below — a decisive break under it would weaken the trend.
The nearest floor, 8.8% below — buyers have tended to step in here.
The nearest ceiling, 8.2% above — a clean break opens room to run.
A major ceiling 16.7% above — clearing it would confirm fresh momentum.
Key EOLS support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of EOLS market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $6.84 | Sell | $6.79 | Sell |
| MA 10 | $6.90 | Sell | $6.83 | Sell |
| MA 20 | $6.82 | Sell | $6.78 | Sell |
| MA 50 | $6.52 | Buy | $6.42 | Buy |
| MA 100 | $5.58 | Buy | $6.10 | Buy |
| MA 200 | $5.90 | Buy | $6.46 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 47.10 | Neutral |
| Stoch RSI (14) | 0.00 | Buy |
| CCI (20) | -89.14 | Neutral |
| Williams %R (14) | -96.43 | Info |
| MACD (12,26,9) | -0.06 | Sell |
| ROC (12) | -1.93 | Sell |
| Bollinger %B (20,2) | 0.21 | Neutral |
| Stochastic %K (14) | 3.57 | Buy |
| TRIX (15) | 0.35 | Buy |
| Awesome (5,34) | 0.17 | Buy |
| Ultimate (7,14,28) | 40.01 | Neutral |
| Momentum (10) | -0.54 | Sell |
| Aroon Osc (25) | 60.00 | Buy |
| Hull MA (9) | 6.76 | Sell |
| ADX (14) | 17.58 | Neutral |
| ATR (14) | 0.13 | Info |
The near-term technical picture shows bullish sentiment with RSI14 at 50. The stock trades above the SMA50 of $6.52 and above the SMA200 of $5.90, suggesting a constructive setup. Support is at $6.03 and resistance at $7.15, with a 30-day range of $5.71 to $7.66.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $3.94 | $6.61 | $8.76 | 0% | Neutral | |
| $7.07 | $8.73 | $11.33 | +32% | Bullish | |
| $8.56 | $10.80 | $14.46 | +63% | Bullish | |
| $9.10 | $11.70 | $16.05 | +77% | Bullish | |
| $9.82 | $12.83 | $17.97 | +94% | Bullish | |
| $10.44 | $13.85 | $19.74 | +109% | Bullish | |
| $11.02 | $14.82 | $21.47 | +124% | Bullish | |
| $12.29 | $16.74 | $24.62 | +153% | Bullish | |
| $14.36 | $19.79 | $29.49 | +199% | Bullish | |
| $16.46 | $22.95 | $34.64 | +247% | Bullish | |
| $22.22 | $32.62 | $51.93 | +394% | Bullish | |
| $38.18 | $61.15 | $105.27 | +825% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $3.94 | $6.61 | $7.90 | +0.00% |
| August 2026 | $5.77 | $6.78 | $8.16 | +2.60% |
| September 2026 | $5.66 | $6.69 | $8.12 | -1.35% |
| October 2026 | $5.56 | $6.60 | $8.08 | -1.29% |
| November 2026 | $5.74 | $6.84 | $8.41 | +3.51% |
| December 2026 | $5.92 | $7.08 | $8.76 | +3.54% |
Click any year to see its month-by-month EOLS forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Evolus, Inc.'s 2026 outlook centres on $6.61, within a $3.94 to $8.76 range. That marks a 0% change versus current levels. Price action looks broadly range-bound.
By 2027, EOLS could reach as high as $11.33, with a base case around $8.73 and support toward $7.07 — roughly +32% from $6.61. Buyers look set to stay in control over this stretch.
Expect EOLS to range from $8.56 to $14.46 through 2028. The $10.80 average target implies a +63% move from current prices. That is up +24% on the projected 2027 average. Momentum favours further upside here.
The EOLS price prediction for 2029 points to an average of $11.70 (low $9.10, high $16.05) — a potential gain of +77% on today's $6.61. Buyers look set to stay in control over this stretch.
In 2030, EOLS is projected to trade between $9.82 and $17.97, averaging $12.83 — a potential gain of +94% from today's $6.61. That is up +10% on the projected 2029 average. Momentum favours further upside here.
Evolus, Inc.'s 2031 outlook centres on $13.85, within a $10.44 to $19.74 range. That is up +8% on the projected 2030 average. That marks a +109% change versus current levels. Buyers look set to stay in control over this stretch.
By 2032, EOLS could reach as high as $21.47, with a base case around $14.82 and support toward $11.02 — roughly +124% from $6.61. Momentum favours further upside here.
Expect EOLS to range from $12.29 to $24.62 through 2033. The $16.74 average target implies a +153% move from current prices. That is up +13% on the projected 2032 average. Buyers look set to stay in control over this stretch.
The EOLS price prediction for 2034 points to an average of $19.79 (low $14.36, high $29.49) — a potential gain of +199% on today's $6.61. Momentum favours further upside here.
In 2035, EOLS is projected to trade between $16.46 and $34.64, averaging $22.95 — a potential gain of +247% from today's $6.61. That is up +16% on the projected 2034 average. Buyers look set to stay in control over this stretch.
Evolus, Inc.'s 2040 outlook centres on $32.62, within a $22.22 to $51.93 range. That is up +42% on the projected 2035 average. That marks a +394% change versus current levels. Momentum favours further upside here.
By 2050, EOLS could reach as high as $105.27, with a base case around $61.15 and support toward $38.18 — roughly +825% from $6.61. Buyers look set to stay in control over this stretch.
Investing $1,000 in EOLS today (≈ 151.28593 EOLS) could be worth
$9,251.6
+$8,251.6 (+825%) by 2050 · US Dollar
Based on the average projected EOLS price of $61.15 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in EOLSwould be worth at today's price.
$1,000 invested in EOLS on Jul 10, 2025 (≈ 102.774928 EOLS) would be worth
$679.34
-$320.66 (-32.1%) today · 0.68× · US Dollar
Based on a EOLS entry price of $9.73 vs. today's $6.61.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $6.9 | $957.97 | -4.2% |
| 1 month ago | $6.72 | $983.63 | -1.6% |
| 3 months ago | $4.27 | $1,548.01 | +54.8% |
| 6 months ago | $5.77 | $1,145.58 | +14.6% |
| 1 year ago | $9.73 | $679.34 | -32.1% |
| All time (5.0y) ago | $12.08 | $547.19 | -45.3% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our EOLS forecast.
Our base-case forecast reaches $13.00 around 2031.
Implied market cap at $13.00: $856.11M
The multi-year forecast points to meaningful upside. In 2026 the avg is $6.61 with a min of $3.94 and a max of $8.76 (ROI 0%, sentiment NEUTRAL). By 2030 the avg is $12.83 with a min of $9.82 and a max of $17.97 (ROI 94.2%, sentiment BULLISH).
In 2040 the avg is $32.62 with a min of $22.22 and a max of $51.93 (ROI 393.6%, sentiment BULLISH), and in 2050 the avg rises to $61.15 with a min of $38.18 and a max of $105.27 (ROI 825.2%, sentiment BULLISH). Throughout 2027–2029 the forecast shows continued upside, culminating in a strong long-term bullish stance, though these are estimates and not guarantees.
Tap a question to reveal the answer.
Avg $12.83; min $9.82; max $17.97; ROI 94.2%; sentiment BULLISH.
The forecast shows bullish sentiment from 2027 onward with rising averages and upside potential (e.g., 2027 avg $8.73, ROI 32.1%; 2029 avg $11.70, ROI 77%), but these are estimates and not guarantees.
Yes. The 2040 max is $51.93 and the 2050 max is $105.27, indicating potential to exceed $50 in the 2040–2050 horizon.
Current price $6.61; market cap $435.3M.
Avg $61.15; min $38.18; max $105.27; ROI 825.2%; sentiment BULLISH.
Evolus, Inc. Community Discussion
0Share your Evolus, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.